Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature

Standard

Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature. / Janjetovic, Snjezana; Janning, Melanie; Daukeva, Liliana; Bokemeyer, Carsten; Fiedler, Walter.

In: TUMORI J, Vol. 99, No. 3, 2013, p. e96-9.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{6e22d719667e404ca8521085d161ee2c,
title = "Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature",
abstract = "BACKGROUND: Chylothorax is defined as chyle entering the pleural space. The most common causes of chylothorax are lymphoma followed by bronchogenic carcinoma and trauma.CASE REPORT: We report a case of chylothorax in a patient with Hodgkin's lymphoma. A 28-year old man was admitted to the hospital with exertional dyspnea and dry cough. A chest X-ray showed the large opacity on the left side suggesting to the presence of pleural effusion.METHODS: The effusion was drained, and biochemical tests of the pleural fluid revealed high contents of triglycerides and, hence, confirmed the diagnosis of chylothorax. Cytology of the pleural fluid showed no evidence of Hodgkin's cells. Computer tomography scans of the chest and abdomen exhibited the presence of a soft tissue mass located in the left mediastinum. Mediastinal mass biopsy led to diagnosis of Hodgkin's lymphoma of the nodular sclerosis subtype. The patient received the standard treatment with two cycles of chemotherapy with prednisolone, doxorubicin, cyclophosphamide, vincristine, bleomycin, procarbazine, and etoposide (BEACOPP), followed by an additional two cycles of therapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). ResULTS: After one cycle of chemotherapy, chylothorax initially decreased. Unfortunately, during the following courses of chemotherapy, the pleural effusion reoccurred and repeated pleural taps were necessary. According to the treatment protocol, radiation of the mediastinal bulk was performed after chemotherapy. Now, nearly one year after completion of radiotherapy, the chylothorax has significantly regressed and no further thoracocenteses were necessary.CONCLUSION: The case reveals an example of left-sided chylothorax as the first manifestation of Hodgkin's lymphoma in a young patient. In this case, radiotherapy was shown to be an effective treatment option for lymphoma-associated chylothorax unresponsive to chemotherapy.",
keywords = "Adult, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Chylothorax, Cyclophosphamide, Dacarbazine, Disease-Free Survival, Doxorubicin, Drug Resistance, Neoplasm, Etoposide, Hodgkin Disease, Humans, Male, Mediastinal Neoplasms, Prednisone, Procarbazine, Vinblastine, Vincristine",
author = "Snjezana Janjetovic and Melanie Janning and Liliana Daukeva and Carsten Bokemeyer and Walter Fiedler",
year = "2013",
doi = "10.1700/1334.14813",
language = "English",
volume = "99",
pages = "e96--9",
journal = "TUMORI J",
issn = "0300-8916",
publisher = "Wichtig Publishing",
number = "3",

}

RIS

TY - JOUR

T1 - Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature

AU - Janjetovic, Snjezana

AU - Janning, Melanie

AU - Daukeva, Liliana

AU - Bokemeyer, Carsten

AU - Fiedler, Walter

PY - 2013

Y1 - 2013

N2 - BACKGROUND: Chylothorax is defined as chyle entering the pleural space. The most common causes of chylothorax are lymphoma followed by bronchogenic carcinoma and trauma.CASE REPORT: We report a case of chylothorax in a patient with Hodgkin's lymphoma. A 28-year old man was admitted to the hospital with exertional dyspnea and dry cough. A chest X-ray showed the large opacity on the left side suggesting to the presence of pleural effusion.METHODS: The effusion was drained, and biochemical tests of the pleural fluid revealed high contents of triglycerides and, hence, confirmed the diagnosis of chylothorax. Cytology of the pleural fluid showed no evidence of Hodgkin's cells. Computer tomography scans of the chest and abdomen exhibited the presence of a soft tissue mass located in the left mediastinum. Mediastinal mass biopsy led to diagnosis of Hodgkin's lymphoma of the nodular sclerosis subtype. The patient received the standard treatment with two cycles of chemotherapy with prednisolone, doxorubicin, cyclophosphamide, vincristine, bleomycin, procarbazine, and etoposide (BEACOPP), followed by an additional two cycles of therapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). ResULTS: After one cycle of chemotherapy, chylothorax initially decreased. Unfortunately, during the following courses of chemotherapy, the pleural effusion reoccurred and repeated pleural taps were necessary. According to the treatment protocol, radiation of the mediastinal bulk was performed after chemotherapy. Now, nearly one year after completion of radiotherapy, the chylothorax has significantly regressed and no further thoracocenteses were necessary.CONCLUSION: The case reveals an example of left-sided chylothorax as the first manifestation of Hodgkin's lymphoma in a young patient. In this case, radiotherapy was shown to be an effective treatment option for lymphoma-associated chylothorax unresponsive to chemotherapy.

AB - BACKGROUND: Chylothorax is defined as chyle entering the pleural space. The most common causes of chylothorax are lymphoma followed by bronchogenic carcinoma and trauma.CASE REPORT: We report a case of chylothorax in a patient with Hodgkin's lymphoma. A 28-year old man was admitted to the hospital with exertional dyspnea and dry cough. A chest X-ray showed the large opacity on the left side suggesting to the presence of pleural effusion.METHODS: The effusion was drained, and biochemical tests of the pleural fluid revealed high contents of triglycerides and, hence, confirmed the diagnosis of chylothorax. Cytology of the pleural fluid showed no evidence of Hodgkin's cells. Computer tomography scans of the chest and abdomen exhibited the presence of a soft tissue mass located in the left mediastinum. Mediastinal mass biopsy led to diagnosis of Hodgkin's lymphoma of the nodular sclerosis subtype. The patient received the standard treatment with two cycles of chemotherapy with prednisolone, doxorubicin, cyclophosphamide, vincristine, bleomycin, procarbazine, and etoposide (BEACOPP), followed by an additional two cycles of therapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). ResULTS: After one cycle of chemotherapy, chylothorax initially decreased. Unfortunately, during the following courses of chemotherapy, the pleural effusion reoccurred and repeated pleural taps were necessary. According to the treatment protocol, radiation of the mediastinal bulk was performed after chemotherapy. Now, nearly one year after completion of radiotherapy, the chylothorax has significantly regressed and no further thoracocenteses were necessary.CONCLUSION: The case reveals an example of left-sided chylothorax as the first manifestation of Hodgkin's lymphoma in a young patient. In this case, radiotherapy was shown to be an effective treatment option for lymphoma-associated chylothorax unresponsive to chemotherapy.

KW - Adult

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Bleomycin

KW - Chylothorax

KW - Cyclophosphamide

KW - Dacarbazine

KW - Disease-Free Survival

KW - Doxorubicin

KW - Drug Resistance, Neoplasm

KW - Etoposide

KW - Hodgkin Disease

KW - Humans

KW - Male

KW - Mediastinal Neoplasms

KW - Prednisone

KW - Procarbazine

KW - Vinblastine

KW - Vincristine

U2 - 10.1700/1334.14813

DO - 10.1700/1334.14813

M3 - SCORING: Journal article

C2 - 24158090

VL - 99

SP - e96-9

JO - TUMORI J

JF - TUMORI J

SN - 0300-8916

IS - 3

ER -